Robert Becker, PhD Joins Particle Sciences as Vice President Biosciences Sales & Business Development - Tucson News Now

Robert Becker, PhD Joins Particle Sciences as Vice President Biosciences Sales & Business Development

  • HealthMore>>

  • FDA to propose e-cigarette regulations

    FDA to propose e-cigarette regulations

    © FDA© FDA
    The U.S. Food and Drug Administration is proposing long-awaited regulations governing the fast-growing electronic cigarette industry.
    The U.S. Food and Drug Administration is proposing long-awaited regulations governing the fast-growing electronic cigarette industry.
  • People seek out health info when famous person dies

    People seek out health info when famous person dies

    WEDNESDAY, April 23, 2014 (HealthDay News) -- The deaths of well-known people offer an opportunity to educate the general public about disease detection and prevention, a new study suggests. Researchers surveyed 1,400 American men and women after Apple co-founder Steve Jobs died of pancreatic cancer in 2011 and learned that more than one-third of them sought information about his cause of death or information about cancer in general soon after his death was reported. About 7 percent of th...
    WEDNESDAY, April 23, 2014 (HealthDay News) -- The deaths of well-known people offer an opportunity to educate the general public about disease detection and prevention, a new study suggests. Researchers surveyed 1,400 American men and women after Apple co-founder Steve Jobs died of pancreatic cancer in 2011 and learned that more than one-third of them sought information about his cause of death or information about cancer in general soon after his death was reported. About 7 percent of th...
  • 1 in 13 U.S. schoolkids takes psych meds

    1 in 13 U.S. schoolkids takes psych meds

    More than 7 percent of American schoolchildren are taking at least one medication for emotional or behavioral difficulties, a new government report shows.
    More than 7 percent of American schoolchildren are taking at least one medication for emotional or behavioral difficulties, a new government report shows.

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Particle Sciences, Inc.

BETHLEHEM, Pa., Feb. 4, 2014 /PRNewswire/ -- Particle Sciences, Inc. today announced the appointment of Robert Becker to the position of Vice President Biosciences Sales and Business Development.  Dr. Becker, who holds a PhD in Microbiology and Immunology from the University of Kansas and an MBA from Columbia Business School, joins Particle Sciences following more than 24 years of experience in biopharmaceutical scientific and business leadership roles ranging from management of research & development teams and business development at what is today Sanofi Pasteur, to running business and corporate development operations at biotechnology and medical devices companies, VaxInnate and MedInstill. In his commercial career, Dr. Becker has established a long history of leading business and research & development activities that depend upon collaborations and partnerships between companies, and in some cases with the US Government. 

Dr. Mark Mitchnick, Particle Sciences, CEO notes that, "Bob brings a wealth of experience to the Particle Sciences team.  We are bringing Bob on to manage our growing portfolio of large molecule delivery systems.  Having spent years in a scientific development role and then moving into operational and business development positions, Bob has a real understanding of our space and our clients' needs.  Bob will also handle government contracting, an area of increasing opportunity for us."

Particle Sciences is an integrated provider of drug development services.  Particle Sciences focuses on BCS II/III/IV molecules, biologics and highly potent compounds through a variety of technologies including emulsions, gels, micro and nano-particulates, drug/device combination products, solid solutions and others. Through a full range of formulation, analytic, and manufacturing services, Particle Sciences provides pharmaceutical companies with a complete and seamless development solution that minimizes the time and risk between discovery and the clinic.  We also have an extensive history in government contracting alongside our clients.  The company was founded in 1991 and is headquartered in Bethlehem, Pennsylvania.  Visit www.particlesciences.com, email info@particlesciences.com or contact us at (610) 861- 4701 for information.

Contact: Maureen Grieco
Maureen.Grieco@particlesciences.com

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow